Lingfeng Zhong

412 total citations
24 papers, 275 citations indexed

About

Lingfeng Zhong is a scholar working on Molecular Biology, Fluid Flow and Transfer Processes and Nephrology. According to data from OpenAlex, Lingfeng Zhong has authored 24 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Fluid Flow and Transfer Processes and 3 papers in Nephrology. Recurrent topics in Lingfeng Zhong's work include Inflammasome and immune disorders (8 papers), Advanced Combustion Engine Technologies (7 papers) and Gout, Hyperuricemia, Uric Acid (3 papers). Lingfeng Zhong is often cited by papers focused on Inflammasome and immune disorders (8 papers), Advanced Combustion Engine Technologies (7 papers) and Gout, Hyperuricemia, Uric Acid (3 papers). Lingfeng Zhong collaborates with scholars based in China, United States and Netherlands. Lingfeng Zhong's co-authors include Bozhi Ye, Lan Su, Shanshan Dai, Weijian Huang, Jibo Han, Shuang Lin, Guangju Zhao, Yucong Zhang, Guangliang Hong and Xueli Cai and has published in prestigious journals such as Nature Communications, Gastroenterology and Hypertension.

In The Last Decade

Lingfeng Zhong

19 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfeng Zhong China 9 185 68 49 34 26 24 275
Fotis Panagopoulos Greece 9 113 0.6× 20 0.3× 33 0.7× 29 0.9× 78 3.0× 26 316
Joanne L. Dunster United Kingdom 11 94 0.5× 88 1.3× 8 0.2× 55 1.6× 26 1.0× 27 335
Katja Dahlke Germany 9 96 0.5× 77 1.1× 21 0.4× 21 0.6× 44 1.7× 18 309
Yiyang Tang China 12 42 0.2× 87 1.3× 32 0.7× 62 1.8× 32 1.2× 39 338
Fábio Antônio Gaiotto Brazil 8 58 0.3× 20 0.3× 22 0.4× 72 2.1× 42 1.6× 38 221
Mingli Zhu China 12 92 0.5× 44 0.6× 113 2.3× 24 0.7× 73 2.8× 41 393
Qing-Yun Hao China 10 50 0.3× 23 0.3× 15 0.3× 77 2.3× 41 1.6× 22 267
Jicheng Zhang China 8 48 0.3× 36 0.5× 19 0.4× 12 0.4× 24 0.9× 20 212
Qingli Cai China 4 135 0.7× 176 2.6× 18 0.4× 15 0.4× 31 1.2× 9 433

Countries citing papers authored by Lingfeng Zhong

Since Specialization
Citations

This map shows the geographic impact of Lingfeng Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng Zhong more than expected).

Fields of papers citing papers by Lingfeng Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfeng Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng Zhong. The network helps show where Lingfeng Zhong may publish in the future.

Co-authorship network of co-authors of Lingfeng Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfeng Zhong. A scholar is included among the top collaborators of Lingfeng Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfeng Zhong. Lingfeng Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ye, Bozhi, Lingfeng Zhong, Yi Wang, et al.. (2025). Ubiquitin‐specific protease 25 improves myocardial ischemia–reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes. Clinical and Translational Medicine. 15(2). e70243–e70243. 4 indexed citations
3.
Zhong, Lingfeng, Shanshan Dai, Fan Yu, et al.. (2025). Cardiomyocyte‐Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination. Advanced Science. 12(23). e2416478–e2416478.
4.
Yu, Fan, Guo‐Ping Shi, Lingfeng Zhong, et al.. (2025). Cardiomyocyte lncRNA Cpat maintains cardiac homeostasis and mitochondria function by targeting citrate synthase acetylation. Nature Communications. 16(1). 9022–9022.
5.
Zhong, Lingfeng, et al.. (2025). Air system optimization coupled with electric supercharger matching of a two-stroke aircraft engine based on machine learning and NSGA-III. Aerospace Science and Technology. 162. 110234–110234. 2 indexed citations
6.
Zhong, Lingfeng, et al.. (2025). Dual regulatory mechanisms and boundary conditions of digital transformation on open innovation: A supply chain dynamic characteristics perspective. Technology in Society. 84. 103085–103085. 1 indexed citations
7.
8.
Yuan, Hong, et al.. (2024). Investigation on multi-objective following control algorithm for vehicle adaptive cruise control under cruise state. Proceedings of the Institution of Mechanical Engineers Part D Journal of Automobile Engineering. 239(7). 2781–2796. 1 indexed citations
9.
Han, Jibo, Lingfeng Zhong, Yucong Zhang, et al.. (2024). Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB Axis. Arteriosclerosis Thrombosis and Vascular Biology. 44(6). 1365–1378. 38 indexed citations
10.
Cai, Ying, et al.. (2024). Multicomponent comprehensive confirms that erythroferrone is a molecular biomarker of pan-cancer. Heliyon. 10(5). e26990–e26990. 1 indexed citations
11.
Dai, Shanshan, Jibo Han, Lingfeng Zhong, et al.. (2023). Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD. Phytomedicine. 121. 155105–155105. 22 indexed citations
12.
Zhong, Lingfeng, et al.. (2023). An Unusual Cause of Abdominal Pain. Gastroenterology. 165(5). 1114–1117. 1 indexed citations
13.
Zhong, Lingfeng, et al.. (2023). Compressor Performance Prediction Based on the Interpolation Method and Support Vector Machine. Aerospace. 10(6). 558–558. 13 indexed citations
14.
Zhong, Lingfeng, Jibo Han, Zhouqing Huang, et al.. (2023). Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formation. Basic Research in Cardiology. 118(1). 40–40. 28 indexed citations
15.
Zhong, Lingfeng, et al.. (2023). Numerical investigation on the spray characteristics of biodiesel with gas-assisted atomization injection. Fuel. 358. 130178–130178. 7 indexed citations
16.
Zhong, Lingfeng, Bozhi Ye, Zhe Wang, et al.. (2022). Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways. Cardiovascular Drugs and Therapy. 37(6). 1131–1141. 8 indexed citations
17.
18.
Zhong, Lingfeng, et al.. (2022). Integrated Analysis of circRNA-miRNA-mRNA ceRNA Network in Cardiac Hypertrophy. Frontiers in Genetics. 13. 781676–781676. 10 indexed citations
19.
Ye, Bozhi, Shuang Lin, Lingfeng Zhong, et al.. (2022). Elevated circulating levels of gasdermin D are related to acute myocardial infarction and pyrogptosis. BMC Cardiovascular Disorders. 22(1). 554–554. 9 indexed citations
20.
Dai, Shanshan, Bozhi Ye, Lingfeng Zhong, et al.. (2021). GSDMD Mediates LPS-Induced Septic Myocardial Dysfunction by Regulating ROS-dependent NLRP3 Inflammasome Activation. Frontiers in Cell and Developmental Biology. 9. 779432–779432. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fotis Panagopoulos Breakdown of academic impact, for papers by Joanne L. Dunster Breakdown of academic impact, for papers by Katja Dahlke Breakdown of academic impact, for papers by Yiyang Tang Breakdown of academic impact, for papers by Fábio Antônio Gaiotto Breakdown of academic impact, for papers by Mingli Zhu Breakdown of academic impact, for papers by Qing-Yun Hao Breakdown of academic impact, for papers by Jicheng Zhang Breakdown of academic impact, for papers by Qingli Cai
Rankless by CCL
2026